Acr Convergence 2024 Dates And Times. New advancements and proven approaches across the practice of rheumatology will be at the forefront of the interprofessional programming at acr convergence 2024. We would like to show you a description here but the site won’t allow us.
Explore the annual meeting program, abstract. New phase 2b study results for zasocitinib, an investigational oral selective tyrosine kinase 2 (tyk2) inhibitor, will be presented at the american college of rheumatology (acr) convergence 2024 in washington, d.c.
Acr Convergence 2024 Dates And Times Images References :
